| P50 | author | Maria Pia Amato | Q56451881 |
| P2093 | author name string | Marco Allinovi | |
| | Leonardo Caroti | |
| | Silvia Farsetti | |
| | Enrico Eugenio Minetti | |
| | Calogero Lino Cirami | |
| | Giulia Antognoli | |
| P2860 | cites work | Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature | Q26864297 |
| | Drug-induced glomerular disease: direct cellular injury | Q27692666 |
| | Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome | Q33384133 |
| | Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report | Q33395870 |
| | Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report | Q33397657 |
| | Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis | Q33409827 |
| | Clinical toxicity of interferons in cancer patients: a review | Q33411253 |
| | Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report | Q33413137 |
| | Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β. | Q33413368 |
| | Thrombotic microangiopathy associated with interferon beta | Q33414217 |
| | Drug-induced thrombotic microangiopathy: a systematic review of published reports | Q33418784 |
| | Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. | Q33420100 |
| | Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report | Q33429688 |
| | Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia | Q33492873 |
| | 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34351265 |
| | Thrombotic microangiopathy associated with use of interferon-beta | Q36101957 |
| | Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review | Q37522227 |
| | Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases | Q38422043 |
| | Cisplatin-induced haemolytic uraemic syndrome associated with a novel intronic mutation of CD46 treated with eculizumab | Q41865048 |
| | CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency | Q42400206 |
| | Malignant hypertension and interferon-beta: a case report. | Q44268735 |
| | Complement activation in angiotensin II-induced organ damage | Q46658434 |
| | [Thrombotic thrombocytopenic purpura during treatment with interpheron]. | Q50573892 |
| | Hemolytic uremic syndrome: an unusual complication of interferon-β treatment in a MS patient. | Q50959577 |
| | An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosis. | Q51755024 |
| | Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning. | Q53082612 |
| | Investigations on the subclinical and clinical nephrotoxicity of interferon alpha-2B in patients with myeloproliferative syndromes | Q68066089 |
| | Hemolytic uremic syndrome associated with beta-interferon therapy for chronic hepatitis C | Q77216457 |
| | Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis | Q86194106 |
| | Interferon-α-induced thrombotic microangiopathy in patients with chronic myelogenous leukemia | Q87018942 |
| P433 | issue | 5 | |
| P304 | page(s) | 625-631 | |
| P577 | publication date | 2017-02-16 | |
| P1433 | published in | Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) | Q26842221 |
| P1476 | title | Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab | |
| P478 | volume | 10 | |